Randall is a seasoned healthcare industry thought leader, executive, and consultant with extensive experience in commercialization, national accounts, and business development. He has played pivotal roles in market entry, commercial infrastructure development, and customer strategy for leading companies such as Endo Pharmaceuticals, Apotex, U.S. Antibiotics, and Théa Pharma. Throughout his career, Randall has also contributed to established firms including Duramed, Sandoz, Allergan, Praelia, and Prasco. As a key industry leader, his expertise in forging strong relationships with key decision-makers in drug development, reimbursement, and product delivery has been instrumental in driving business growth and success across the pharmaceutical landscape.

Sumeet is an accomplished senior executive in the biopharmaceutical industry with over 24 years of global cross-functional experience across the healthcare value chain, leading global business development, operations, product development and commercialization. He has established and successfully run business units managing P&L in US, EU and Asia.  Sumeet has also developed growth strategies and built successful partnerships for multiple biotech and med device startups. Sumeet holds a Ph.D. in Pharmacy from University of Illinois at Chicago and an M.B.A. from the Kellogg School of Management.

Tim is a veteran regulatory affairs expert in the animal health industry, with leadership roles in both emerging and established multi-national organizations. His career highlights include successfully guiding new animal drug approvals through the FDA's Center for Veterinary Medicine. Tim's extensive regulatory knowledge and technical expertise enable him to develop innovative solutions for clients navigating complex approval processes. He has also fostered valuable collaborations between industry and regulatory agencies through his involvement in trade associations. Tim's unique skill set makes him adept at strategizing and executing effective regulatory pathways in the dynamic animal health sector.

Erik is a dynamic financial executive with a proven track record in the pharmaceutical industry.He excels in building robust financial foundations for growth, with expertise in accounting, financial planning, SEC reporting, and strategic finance. Erik's entrepreneurial approach drives scalable solutions and process improvements, optimizing financial systems and empowering teams. As a trusted advisor, he leverages technical proficiency to guide data-driven decisions and innovative strategies, steering companies towards sustainable growth and operational excellence for your financial consulting needs.

‍

Mike Scallon is a senior marketer who has held key roles with such leading organizations as McKesson and AT&T Wireless. His strengths include driving results from complex challenges including making products and services easier to understand for the end-user and sales force. He has an exceptional background in such key marketing disciplines as brand management, new product development, digital marketing, e-commerce, direct marketing, advertising, marketing research, promotion, field marketing, customer relationship management and supplier management.

Brady has driven impactful results across various industries, securing $35 million in funding for my last two companies. With expertise in growth strategy, business process optimization, and capital raising, he's spent 11 years on the board of BioCorRx Inc. and BioCorRx Pharmaceuticals, Inc., where he held roles including COO, CEO, and President. During his tenure, he led the development of a naltrexone implant aimed at battling addiction, overseeing the project from initial R&D through non-clinical studies and the first Phase 1 human trials. Additionally, he is an inventor on two issued patents, with others pending. Before his time at BioCorRx®, he spent 12 years at iHeartMedia, where he managed marketing campaigns for both local businesses and national brands like Neutrogena, Paramount Pictures, and Samsung. He also managed endorsements for Ryan Seacrest and received the Pinnacle Award for being the top sales executive in the Western region, growing new business by 49% in his first year as Director of Business Development.

Rich Franchi is a pharmaceutical executive with over 30 years in pharmaceutical sales leadership. He has driven success across multiple product categories including generics, branded, injectables and OTC. HIs executive experience at G&W Laboratories, Dava Pharmaceuticals, Endo Pharmaceuticals, and most recently as VP of National Accounts at TWI Pharmaceuticals has honed his skills in strategy development and implementation. His ability to build a team, his market knowledge and his extensive network of relationships drive results with a broad retail, wholesale and government customer base that includes key accounts such as Red Oak Sourcing, WBAD, and Clarus One, Golden State Medical and Proficient RX.

Lauren McCandless, a graphic designer with a B.A. from Point Loma Nazarene University, combines creativity and technical skill in her work. Proficient in Adobe Creative Cloud, she excels in branding, digital media, and print design. Lauren's passion for illustration and innovation drives her to create impactful visual solutions for forward-thinking teams.‍‍‍‍

Chris is a successful executive in the biopharmaceutical industry with more than 25 years of experience. He has strong expertise in corporate strategy, business development, marketing, sales, therapeutic area analysis, commercial operations, and commercial assessment. Chris has previously held roles as Chief Commercial Officer, VP of Commercial Strategy, and Head of Sales and Marketing. He has been responsible for building and leading commercial organizations both in the US and globally. Chris has a BS in Biology from University of California at Irvine and an MBA from Williams College of Business at Xavier University.